American Regent is recalling all lots of Ketorolac Tromethamine Injection ... anaphylactic reactions and local irritation at the injection site and present other risks. No incidents or injuries ...

The recall involves one lot of Ketorolac Tromethamine Injection USP ... in local irritation of blood vessels, swelling at injection site, tissue inflammation and infection, blood clots traveling ...

More information is available in a company news release, available on the FDA Web site. Adverse events related to ketorolac tromethamine injection, 30 mg/mL, may be communicated to the FDA's ...

Ketorolac tromethamine injection ... vessels and result in local irritation of blood vessels, swelling at the site of injection, a mass of tissue that could become inflamed and infected, blood ...

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP 30mg/mL, 1mL Fill/2mL Vials Due to the Potential Presence of Small Particulates March 3 ...

Morningstar brands and products Company Portfolio ...

--(BUSINESS WIRE)--Fresenius Kabi USA is voluntarily recalling a single lot of Ketorolac Tromethamine ... swelling at the site of injection, a mass of tissue that could become inflamed and ...

Three schools said they don't use it, the other six schools, including Nebraska, said they use it.The University of Nebraska detailed the team's use of ketorolac injections, saying three criteria ...

Ultimately, 31,046 Caldolor and 124,184 ketorolac adult patients were selected and compared for ADRs and subsequent healthcare resource utilization, which includes inpatient, outpatient and ...

This extensive, retrospective, payer database analysis evaluated the records of over 17 million patients who had received either ketorolac or Caldolor. Ultimately, 31,046 Caldolor and 124,184 ...